Literature DB >> 22922575

Facial onset sensorimotor neuronopathy syndrome: a case series.

Dobrin Dobrev1, Richard J Barohn, Neil E Anderson, Dean Kilfoyle, Saud Khan, April L McVey, Laura Herbelin, Mazen M Dimachkie.   

Abstract

OBJECTIVE: Facial onset sensorimotor neuronopathy (FOSMN) is a recently described neurological syndrome characterized by slow onset of facial sensory abnormalities and subsequent development of motor deficits. Except for 1 patient, FOSMN has so far been identified only in men.
METHODS: We describe a case series of 3 women with FOSMN. We report their clinical, laboratory, and neurophysiological findings.
RESULTS: The age of onset ranged from 39 to 72 years (mean, 60 years) with presentation 4-7 years after symptom onset. The first symptom was slowly progressive facial numbness, which was followed years later by dysphagia and impaired corneal reflexes. Dysarthria occurred in 2 patients, and mild arm weakness was noted in 2. Muscle stretch reflexes were increased in 1 patient, and in another case, arm sensation was reduced. Laboratory studies were unremarkable, and magnetic resonance imaging of the brain in 3 patients and of the cervical spine in 2 patients was normal. Nerve conduction studies showed reduced leg compound muscle action potential amplitudes in 1 patient and asymmetrically reduced arm sensory nerve action potentials in another case. In 2 patients, electromyography showed widespread active denervation in arm muscles in conjunction with the involvement of leg muscles in 1 case and the tongue in the other patient. We identified chronic neurogenic motor unit action potentials in the genioglossus muscle of all 3 cases while facial EMG performed in case 3 showed similar findings. Blink reflexes were abnormal in all patients. We treated 1 patient with high-dose intravenous methylprednisolone followed by intravenous immunoglobulin without any improvement, and she required percutaneous endoscopic gastrostomy (PEG) tube placement.
CONCLUSIONS: This is the first case series describing 3 women with the FOSMN syndrome. We expand phenotype of FOSMN to include upper motor neuron signs and normal arm sensory nerve action potentials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922575     DOI: 10.1097/CND.0b013e31825f82b3

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  5 in total

Review 1.  Facial onset sensory and motor neuronopathy.

Authors:  Qian Zheng; Lan Chu; Liming Tan; Hainan Zhang
Journal:  Neurol Sci       Date:  2016-07-29       Impact factor: 3.307

2.  Trigeminal isolated sensory neuropathy (TISN) and FOSMN syndrome: despite a dissimilar disease course do they share common pathophysiological mechanisms?

Authors:  Giorgio Cruccu; Elena M Pennisi; Giovanni Antonini; Antonella Biasiotta; Giulia di Stefano; Silvia La Cesa; Caterina Leone; Salvatore Raffa; Claudia Sommer; Andrea Truini
Journal:  BMC Neurol       Date:  2014-12-19       Impact factor: 2.474

3.  Oral phase dysphagia in facial onset sensory and motor neuronopathy.

Authors:  Mitsuru Watanabe; Wataru Shiraishi; Ryo Yamasaki; Noriko Isobe; Motohiro Sawatsubashi; Ryuji Yasumatsu; Takashi Nakagawa; Jun-Ichi Kira
Journal:  Brain Behav       Date:  2018-05-21       Impact factor: 2.708

Review 4.  Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology.

Authors:  Eva M J de Boer; Andrew W Barritt; Marwa Elamin; Stuart J Anderson; Rebecca Broad; Angus Nisbet; H Stephan Goedee; Juan F Vázquez Costa; Johannes Prudlo; Christian A Vedeler; Julio Pardo Fernandez; Mónica Povedano Panades; Maria A Albertí Aguilo; Eleonora Dalla Bella; Giuseppe Lauria; Wladimir B V R Pinto; Paulo V S de Souza; Acary S B Oliveira; Camilo Toro; Joost van Iersel; Malu Parson; Oliver Harschnitz; Leonard H van den Berg; Jan H Veldink; Ammar Al-Chalabi; Peter N Leigh; Michael A van Es
Journal:  Neurol Clin Pract       Date:  2021-04

5.  Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy.

Authors:  Besa Ziso; Tim L Williams; R Jon L Walters; Stephan R Jaiser; Johannes Attems; Udo C Wieshmann; A J Larner; Anu Jacob
Journal:  Case Rep Neurol       Date:  2015-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.